They are the most talked-about pharmaceuticals of the last few years. GLP-1s are diabetes drugs that are exploding in ...

The World Health Organization issued new guidelines recommending the use of GLP-1 drugs for adults with obesity and called for action on manufacturing and affordability.

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

New WHO guidance calls for a worldwide obesity treatment “ecosystem” to ensure that GLP-1 weight-loss drugs are used fairly ...

Discover four innovative ways food and beverage brands are catering to GLP-1 users — from slow-release nutrition to ...

The World Health Organization is now recommending GLP-1 drugs for adults trying to manage obesity. Dr. Natalie Azar explains ...

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said ...

Explore GLP-1 receptor agonists with experts Judith Heij-Hadavi and Nicole Snow: molecular design, patient care, oral therapies, and analytical insights.

ABC News’ medical contributor Dr. Alok Patel explains the World Health Organization’s newest guidelines that say GLP-1 medications alone are not a solution for the global obesity epidemic.